A Clinical Trial To Study The Effect of Darunagna Lepa Converted Into Lotion In Dandruff

An Open-Label Clinical Trial To Evaluate The Anti-dandruff Effect of Darunagna Lepa Converted Into Lotion

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039737

Enrollment

Registered

2022-01-27

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L210- Seborrhea capitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having Adherent Scalp Flaking Score (ASFS) score >24. Patients having classical features of darunaka i.e Kandu (Itching) , Kesha bhoomi rookshata (Dryness of scalp) , Kesha chyuti (Hair fall) and Kesha bhoomi prapatana (Flaking).

Exclusion criteria

Exclusion criteria: Diagnosed cases of Psoriasis, Alopecia Ã¢â?¬Â¢ Pregnancy, Lactating women Ã¢â?¬Â¢ Patients under systemic or topical antibiotics, steroids, immunomodulating drugs, and undergone hair growth treatments. Ã¢â?¬Â¢ History of allergic reaction to topically applied hair care products.

Design outcomes

Primary

Measure	Time frame
Subjective evaluation is done by evaluating characteristics of Darunaka like Kandu, Kesha bhumi rukshata and Kesha bhumi prapatana.Timepoint: Assessment will be done on baseline & after 4 weeks.	—

Secondary

Measure	Time frame
Objective evaluation is done by using: Squamometric assessment using dandruff tester [ D Ã¢â?¬â?? SQUAME] ASFS score [ Adherent Scalp Flaking Score] of moderate (25-34) to severe (34-80). Scalp skin parameters using DermaLab.Timepoint: Assessment will be done on baseline and after 4 weeks.	—

Countries

India

Contacts

Public ContactDr Aiswarya Mohan

Amrita School of Ayurveda

aiswaryamohanjuly4@gmail.com8848750050

Outcome results